Anthem (ANTX) Stock Price, News & Analysis

Company Overview

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Key Stats

• Today's Range: $4.45 to $4.92
• 50-Day Range: $2.97 to $5.49
• 52-Week Range: $1.00 to $6.91
• Volume: 101,829 shs
• Average Volume: 230,411 shs
• Market Capitalization: $176.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.00
• Consensus Rating: Hold

Anthem Stock Analysis - MarketRank™

Anthem scored higher than 65% of companies evaluated by MarketBeat, and ranked 259th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Anthem has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Anthem has a consensus price target of $9.00, representing about 84.0% upside from its current price of $4.89.

Amount of Analyst Coverage

Anthem has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Anthem are expected to grow in the coming year, from ($0.91) to ($0.80) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Anthem is -4.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Anthem is -4.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Anthem has a P/B Ratio of 2.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.08% of the float of Anthem has been sold short.

Short Interest Ratio / Days to Cover

Anthem has a short interest ratio ("days to cover") of 3.31, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Anthem has recently increased by 38.73%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Anthem does not currently pay a dividend.

Dividend Growth

Anthem does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.66

News Sentiment

Anthem has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Anthem this week, compared to 0 articles on an average week.

MarketBeat Follows

1 people have added Anthem to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Anthem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $347.00 in company stock.

Percentage Held by Insiders

24.46% of the stock of Anthem is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

90.47% of the stock of Anthem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 5/21/2026
• Jefferies Global Healthcare Conference 2026: 6/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ANTX
• Previous Symbol: NASDAQ:ANTX
• CIK: 1156093
• Web: www.antheminc.com
• Phone: 650-331-9090
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Anthem: $9.00
• High Price Target: $9.00
• Low Price Target: $9.00
• Potential Upside/Downside: +84.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$35.17 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -52.35%
• Return on Assets: -47.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 15.73
• Quick Ratio: 15.73

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.27 per share
• Price / Book: 2.15

Miscellaneous

• Outstanding Shares: 36,020,000
• Free Float: 27,206,000
• Market Cap: $176.14 million
• Optionable: Not Optionable
• Beta: -0.95